Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
WGS
#1574
GeneDx Holdings Corp. Class A Common Stock
79.7
1
+0.35%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+0.35%
Monthly Change
-16.98%
6 month change
-37.42%
Year Change
-21.08%
Previous Close
79.4
3
Open
79.7
1
Bid
Ask
Low
79.7
1
High
79.7
1
Volume
69
Markets
US Stock Market
Healthcare
WGS
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
1.34 M
7.42 M
11.77 M
26.05 M
28.07 M
29.29 M
—
Valuation ratios
Enterprise value
—
—
—
-30.9 M
2.07 B
3.7 B
11.73 B
Price to earnings ratio
—
—
—
-0.37
-39.62
-178.16
2 056.29
Price to sales ratio
—
—
—
0.32
6.77
8.71
30.64
Price to cash flow ratio
—
—
—
-0.36
-72.53
111.94
-532.38
Price to book ratio
—
—
—
0.28
8.43
12.09
20.21
Enterprise value to EBITDA ratio
—
—
—
0.19
-135.39
3 125.99
3 265.68
Profitability ratios
Return on assets %
—
0.44
1.12
0.42
0.12
0.04
0.05
Return on equity %
—
0.63
2.16
0.77
0.21
0.07
0.08
Return on invested capital %
—
648.97
1 177.56
226.39
36.94
18.96
21.28
Gross margin %
—
7.82
11.4
44.19
63.64
69.74
278.22
Operating margin %
—
210.25
284.48
88.67
7.6
3.06
13.69
EBITDA margin %
—
-197.31
-269.16
-78.25
-5.01
0.28
-6.97
Net margin %
—
115.64
233.91
86.3
17.12
4.92
21.29
Liquidity ratios
Quick ratio
—
4.44
1.38
2.95
3.42
2.34
10.69
Current ratio
14.12
4.77
1.47
3.1
3.61
2.46
11.29
Inventory turnover
—
6.84
11.1
10.03
11.43
10.52
10.9
Asset turnover
—
0.43
0.45
0.45
0.73
0.91
0.91
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
0.02
0.01
0.13
0.12
0.09
0.42
Long term debt to total equity ratio
—
0.03
0.02
0.23
0.21
0.16
0.72
Per share metrics
Operating cash flow per share
—
58.15
31.18
7.41
1.06
1.16
1.15
EBIT per share
—
-134.5
-67.5
-7.37
-0.86
-0.29
-0.68
EBITDA per share
—
-127.84
-61.71
-6.56
-0.57
0.04
-0.35
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
122.32
12.1
5.35
5.25
5.98
21.54
Net current asset value per share
—
147.64
20.77
7.5
7.36
9.37
32.52
Tangible book value per share
—
118.5
6.55
2.28
3.22
4.41
14.69
Working capital per share
—
116.72
6.67
5.08
5.32
5.56
20.81
Book value per share
—
118.5
24.78
9.38
9.12
10.76
39.37
News
GeneDx: The Growth Story Isn't Dead, It's Changing (Rating Upgrade) (NASDAQ:WGS)
These Analysts Slash Their Forecasts On GeneDx After Q4 Results - GeneDx Holdings (NASDAQ:WGS)
BTIG cuts GeneDx stock price target on back-end loaded growth outlook
GeneDx Holdings Corp. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:WGS) 2026-02-23
GeneDx Holdings Corp. (WGS) Q4 2025 Earnings Call Transcript
GeneDx Q4 2025 slides: 54% revenue growth, aggressive 2026 expansion
GeneDx stock maintained at Buy by TD Cowen ahead of results call
Canaccord Genuity reiterates Buy on GeneDx stock, keeps $170 target
GeneDx delivers mixed Q4 results
Investors brace for GeneDx earnings amid profitability questions
GeneDx COO Dechairo sells $510k in WGS stock
Top Healthcare Stocks for This Year According to BTIG